Perpar, A., Brecelj, E., Kozjek, N. R., Anderluh, F., Oblak, I., Vidmar, M. S., & Velenik, V. (2015). Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment. Radiol Oncol.

Perpar, Ana, Erik Brecelj, Nada Rotovnik Kozjek, Franc Anderluh, Irena Oblak, Marija Skoblar Vidmar, and Vaneja Velenik. "Mesenteric Ischemia After Capecitabine Treatment in Rectal Cancer and Resultant Short Bowel Syndrome Is Not an Absolute Contraindication for Radical Oncological Treatment." Radiol Oncol 2015.

Perpar, Ana, et al. "Mesenteric Ischemia After Capecitabine Treatment in Rectal Cancer and Resultant Short Bowel Syndrome Is Not an Absolute Contraindication for Radical Oncological Treatment." Radiol Oncol 2015.